Encompass Health Corp(EHC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #391 of 2,879 stocksTOP 25%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
EHC Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Encompass Health Corp (EHC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores EHC at 68.9/100 on a 32-signal composite quality model, placing it at rank #391 of 2,879 stocks — the top 25% of the AI-ranked universe. EHC scores in the top quartile across balance sheet strength (83.7), revenue scale (80.6). Areas of concern include institutional flow (18.4), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Encompass Health Corp reports quarterly revenue of $1.6B, net income of $194.5M, an operating margin of 18.2%. Top institutional holders of EHC by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. EHC trades on the NYSE exchange and files with the SEC under CIK 785161. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Encompass Health Corp directly from SEC EDGAR. Encompass Health Corp's 13F Pro composite quality score has ranged between 8 and 70 since 2021, currently 68.9 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$1.6B
Net Income
Q1 2026
$194.5M
Free Cash Flow
Q1 2026
$150.7M
Operating Margin
Q1 2026
18.2%
D/E Ratio
Q1 2026
1.02
Get alerted when EHC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Encompass Health Corp including:
Top Institutional Holders of EHC
BlackRock, Inc.
$1.0B10,768,713 shVANGUARD PORTFOLIO MANAGEMENT LLC
$479.7M4,959,545 shVANGUARD CAPITAL MANAGEMENT LLC
$432.0M4,466,237 shWELLINGTON MANAGEMENT GROUP LLP
$372.3M3,848,855 shInvesco Ltd.
$327.5M3,386,105 shSTATE STREET CORP
$304.2M3,144,974 shALLIANCEBERNSTEIN L.P.
$278.2M2,621,245 shFULLER & THALER ASSET MANAGEMENT, INC.
$215.7M2,229,979 shTWO SIGMA INVESTMENTS, LP
$214.9M2,222,101 shGEODE CAPITAL MANAGEMENT, LLC
$183.7M1,898,667 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $1.0B | 10,768,713 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $479.7M | 4,959,545 |
| VANGUARD CAPITAL MANAGEMENT LLC | $432.0M | 4,466,237 |
| WELLINGTON MANAGEMENT GROUP LLP | $372.3M | 3,848,855 |
| Invesco Ltd. | $327.5M | 3,386,105 |
| STATE STREET CORP | $304.2M | 3,144,974 |
| ALLIANCEBERNSTEIN L.P. | $278.2M | 2,621,245 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $215.7M | 2,229,979 |
| TWO SIGMA INVESTMENTS, LP | $214.9M | 2,222,101 |
| GEODE CAPITAL MANAGEMENT, LLC | $183.7M | 1,898,667 |
More Healthcare Companies
View all Healthcare →Put EHC on your watchlist
Track score changes the day Encompass Health Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is EHC a good stock to buy?
13F Pro's AI-powered analysis of Encompass Health Corp (EHC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for EHC are available on the EHC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own EHC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling EHC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Encompass Health Corp's investment landscape.